Clinical Trials Sponsored by Fountain Medical Development Co., Ltd.

Total 1200 results

Taizhou EOC Pharma Co., Ltd.
Fountain Medical Development Co., Ltd.

Completed

Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors

Solid Tumor, Adult

China
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Fountain Medical Development Co., Ltd.

Recruiting

MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Type 2 Diabetes With Diabetic Macular Edema | Type 1 Diabetes With Diabetic Macular Edema

China
Fountain Biopharma Inc.
Oneness Biotech Co., Ltd.

Completed

Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704A

Rheumatoid Arthritis

United States
Peking University Third Hospital
Merck Serono GmbH, Germany; Fountain Medical Development Co., Ltd.; Guangzhou...

Unknown

To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment (CLBR)

Sterility

China
Sinovac Research and Development Co., Ltd.

Not yet recruiting

A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Pneumococcal Infectious Disease

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

COVID-19

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

COVID-19

Brazil
Sinovac Research and Development Co., Ltd.

Completed

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

COVID-19

Dominican Republic
Sinovac Research and Development Co., Ltd.

Suspended

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

COVID-19

Turkey
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Sinovac Research and Development Co., Ltd.

Completed

Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine

COVID-19 | Influenza

China
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 Years

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents

COVID-19

Philippines, Malaysia, Chile, South Africa
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Research and Development Co., Ltd.

Withdrawn

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

COVID-19
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults

Covid19

China
Sinovac Research and Development Co., Ltd.

Recruiting

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

COVID-19

China
Sinovac Research and Development Co., Ltd.

Recruiting

Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

COVID-19

China
Sinovac Research and Development Co., Ltd.

Withdrawn

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

COVID-19

China
Sinovac Research and Development Co., Ltd.

Suspended

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

COVID-19

China
Sinovac Research and Development Co., Ltd.

Completed

Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults

COVID-19

China
CardioNavi MedTech (Wuhan) Co., Ltd.
Beijing Jingruitianhe Medical Science and Technology Development Co,Ltd

Recruiting

The StUdy to Evaluate the Performance and safEty of the Novasight HybRid System Using Objective PeRformance Criteria (SUPERIOR)

Coronary Artery Disease

China
Ningbo Newbay Technology Development Co., Ltd

Recruiting

A Study of NB003 in Patients With Advanced Malignancies

Advanced Solid Tumor

United States, China, Korea, Republic of, Spain, France, United Kingdom
Anda Biopharmaceutical Development (Shenzhen) Co...

Recruiting

Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor

Pancreatic Tumor

China
Ningbo Newbay Technology Development Co., Ltd

Recruiting

A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.

Allergy

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.

Migraine

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

Ischemic Stroke

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Unknown

Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis

Dysmenorrhea

China
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Completed

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

Ischemic Stroke

China
Guizhou Tongjitang Pharmaceutical Co.,Ltd
Beijing Bionovo Medicine Development Co., Ltd.

Unknown

Efficacy and Safety of Runzao Zhiyang Capsule to Treat Chronic Eczema

Chronic Eczema

China
Chongqing Fortune Pharmaceutical Co., Ltd.
Beijing Bionovo Medicine Development Co., Ltd.

Completed

Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations

Parkinson´s Disease

China
BioSpring Medical Co., Ltd

Not yet recruiting

Safety, Tolerability, and Efficacy of MatriPlax in Subjects With Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

Taiwan
JSR Medical Co., Ltd.

Recruiting

Safety and Effectiveness Evaluations of the COLO-BT as an Treatment to the Proctectomy. (COLO-BT)

Colorectal Cancer | Colorectal Surgery | Rectal/Anal

United States
Taewoong Medical Co., Ltd.

Completed

Patency and Safety of the Drug Eluting Covered Biliary Stent Comparing to the Common Covered Biliary Stent (MIRA-cover)

Biliary Stricture | Malignant Neoplasms

Korea, Republic of
Taewoong Medical Co., Ltd.

Completed

A Study to Evaluate the Effectiveness and Safety of EUS-guided Transluminal Drainage With 'Niti-S SPAXUS Stent'

Pancreatic Pseudocyst

Korea, Republic of
Taewoong Medical Co., Ltd.

Completed

Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)

Pancreatic Neoplasms | Biliary Obstruction | Biliary Neoplasms

Korea, Republic of
Taewoong Medical Co., Ltd.

Completed

Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi

Pancreatic Cancer | Cancer of Bile Duct

Korea, Republic of, Japan
BrosMed Medical Co., Ltd

Completed

Efficacy and Safety of Intravascular High-pressure Cutting Balloon Catheters for PCI

Patients With Atherosclerotic Plaques in the Coronary Arteries That Require Excision

China
BrosMed Medical Co., Ltd

Completed

Wedge NC - Scoring Balloon Dilatation Catheter

Coronary Artery Disease

China
Flat Medical Co., Ltd

Unknown

EpiFaith Syringe for Epidural Space Detection

Epidural Localization

Taiwan
Taewoong Medical Co., Ltd.

Terminated

Effectiveness and Safety Confirmation Between FASTSEAL® Bioabsorbable VCD and Perclose® ProGlide SMC System

The Patients Who Needed Hemostasis at the Puncture Site of Common Femoral Artety(CFA) Caused by Femoral Angiogram or Intervention After the Catheter Removal

Korea, Republic of
Andon Medical Co.,Ltd

Completed

Clinical Test of Blood Glucose Test Strips

Diabetes

China
Taewoong Medical Co., Ltd.

Active, not recruiting

Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

Pulmonary Valve Stenosis | Congenital Heart Defect | Pulmonary Valve; Insufficiency, Congenital

Korea, Republic of
BrosMed Medical Co., Ltd

Completed

Evaluate Safety and Efficacy of Pronavi Microcatheter for Use in Endovascular Interventions

Coronary Artery Disease | Peripheral Arterial Disease

China

Clinical Trials Sponsored by Fountain Medical Development Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations